Paradeep Phosphates
- Market Cap
- ₹14,755 Cr
- P/E
- 17.33
Key Fundamentals
SmallcapFertilizers & AgrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 15.40%
- Debt to Equity
- 1.38
- EPS (TTM)
- ₹8.20
- Book Value
- ₹68.80
- Market Cap
- ₹14,755 Cr
- P/E (TTM)
- 17.33
- P/B
- 2.07
- ROE
- 16.20%
- Dividend Yield
- 1.09%
- EBITDA
- ₹2,299 Cr
- 52W High
- ₹170.50
- 52W Low
- ₹99.70
- Day Range
- ₹136.38 – ₹142.82
- Volume
- 17,11,434
Peer Comparison
Commodities › Fertilizers & Agrochemicals › Fertilizers
| 1,996.00 | 37.72 | 58,894 | 4.39 | 0.56% | 16.40% | 22.00% | 33,242 | 1,508 | |
| 757.30 | — | 49,003 | 36.91 | 0.03% | −2.94% | 4.02% | 5,769 | −88 | |
| 371.55 | 7.79 | 14,886 | 1.31 | 1.35% | 20.00% | 25.20% | 20,710 | 1,911 | |
| 142.08 | 17.33 | 14,755 | 2.07 | 1.08% | 16.20% | 15.40% | 23,939 | 852 | |
| 195.14 | 43.08 | 8,954 | 9.35 | 0.26% | 31.30% | 19.30% | 2,139 | 203 | |
| 246.17 | 31.52 | 7,610 | 11.14 | 0.21% | 38.20% | 27.20% | 2,649 | 241 | |
| 103.94 | 12.16 | 5,734 | 1.09 | 2.25% | 7.84% | 10.40% | 18,466 | 473 | |
| Median 7 companies | 246.17 | 24.42 | 14,755 | 4.39 | 0.56% | 16.40% | 19.30% | 18,466 | 473 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 29
- Poor
- Returns, margins, earnings quality 22% weight
- Valuation
- 62
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 56
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 23
- Poor
- Solvency, leverage, coverage 9% weight
- Momentum
- 56
- Good
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company has delivered good profit growth of 35.1% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 22.9%
Weaknesses
2- Company has a low return on equity of 12.3% over last 3 years.
- Company might be capitalizing the interest cost
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bullish | 6 | 5 | 8 |
| Oscillators | Bullish | 1 | 5 | 3 |
| Moving Averages | Neutral | 5 | 0 | 5 |
Oscillators
Bullish
Overall
Bullish
Moving Averages
Neutral
Key readings
- RSI (14)
- 50.93
- Neutral
- MACD (12,26,9)
- −1.18
- Bullish
- SMA (50)
- 145.78
- Bearish
- SMA (200)
- 134.93
- Bullish
As of
Analyst Rating
4 of 4 analysts rate Buy, 0 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 5Y | +33.41% |
|---|---|
| 3Y | +17.83% |
| 1Y | +28.70% |
| TTM | +16.43% |
Net profit
| 5Y | +34.89% |
|---|---|
| 3Y | +48.52% |
| 1Y | +50.45% |
| TTM | −18.08% |
Operating cash flow
| 5Y | Turned negative |
|---|---|
| 3Y | Outflow narrowed by ₹1,365 Cr |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | −0.51 pp |
|---|---|
| 3Y | +4.00 pp |
| 1Y | +0.84 pp |
| TTM | −1.46 pp |
Revenue by year
| Mar 2019 | ₹4,358 Cr |
|---|---|
| Mar 2020 | ₹4,193 Cr |
| Mar 2021 | ₹5,165 Cr |
| Mar 2022 | ₹7,859 Cr |
| Mar 2023 | ₹13,341 Cr |
| Mar 2024 | ₹11,575 Cr |
| Mar 2025 | ₹16,959 Cr |
| Mar 2026 | ₹21,826 Cr |
Net profit by year
| Mar 2019 | ₹159 Cr |
|---|---|
| Mar 2020 | ₹193 Cr |
| Mar 2021 | ₹223 Cr |
| Mar 2022 | ₹398 Cr |
| Mar 2023 | ₹304 Cr |
| Mar 2024 | ₹100 Cr |
| Mar 2025 | ₹662 Cr |
| Mar 2026 | ₹996 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Paradeep Phosphates Ltd trades at ₹141.42 with a market cap of ₹14,687 Cr as of 2026-11-17, reflecting a P/E of 17.25x and an ROE of 14.69%. The company has delivered strong long-term profit growth of 35% CAGR over five years but faces a TTM profit decline of -17%, while carrying a debt-to-equity ratio of 1.02.
- Strong 5-year compounded profit growth of 35% CAGR demonstrates the company's ability to scale earnings over a full business cycle
- ROCE of 23.11% as of 2026-11-17 indicates efficient capital deployment relative to the capital-intensive nature of the fertiliser business
- 3-year compounded sales growth of 18% and 5-year compounded sales growth of 33% reflect sustained topline expansion
- TTM sales growth of 16% shows continued revenue momentum even as profitability has come under pressure
- Healthy dividend payout ratio of 22.9% provides some income return, with a current dividend yield of 1.1%
- Last year ROE of 16% represents an improvement over the 3-year average ROE of 12% and 5-year average ROE of 13%, suggesting an improving return profile
- Stock is trading at ₹141.42 versus a 52-week low of ₹99.70, representing a 42% recovery from its lowest level and a 3-year stock CAGR of 31%
- P/B ratio of 2.06x is reasonable for a company generating 14.69% ROE, suggesting the market is not excessively pricing in growth
- TTM profit has declined by -17%, a sharp reversal from the 48% compounded profit growth over 3 years, signalling potential margin compression
- Debt-to-equity ratio of 1.02 indicates a leveraged balance sheet, which exposes the company to interest rate risk and limits financial flexibility
- Potential capitalisation of interest costs raises concerns about the true profitability picture, as expensing these costs would reduce reported earnings
- 3-year average ROE of only 12% is modest for the level of leverage carried, suggesting the debt has not consistently translated into superior shareholder returns
- Stock trades 17% below its 52-week high of ₹170.50 and has delivered a negative 1-year stock return of -13%, reflecting weakening market sentiment
- As a fertiliser and commodity chemicals business, Paradeep Phosphates is inherently exposed to global phosphoric acid and rock phosphate price volatility, which directly impacts input costs and margins
- P/E of 17.25x against a TTM EPS of ₹8.20 leaves limited room for further multiple expansion if earnings continue to decline
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Paradeep Phosphates faces significant near-term headwinds with Q2FY27 profit down 69% YoY, sharp margin compression from elevated raw material costs, and high subsidy receivables inflating debt. On the positive side, revenue continues to grow, sulphur prices are softening, and the company is investing aggressively in backward integration with a ₹4,750 crore Odisha MoU and phosphoric acid capacity expansion on track for Q1FY28. The trend is currently deteriorating on profitability but could stabilize if raw material costs ease and Rabi season demand supports inventory liquidation.
- Q2 profit crashes 69% YoY Oct 30
Net profit fell 69% YoY to ₹121 crore in Q2FY27 while EBITDA dropped 37% to ₹413.4 crore. EBITDA margin contracted 400bps to 5.6% from 9.6% a year ago, driven by elevated sulphur and raw material costs.
- Stock tumbles 14% post results Oct 30
Shares fell as much as 14% on Oct 30, making Paradeep the biggest loser on the Nifty 500 index following the weak Q2 earnings.
- Sales volumes down 25% YoY Nov 4
Sales volumes declined 25% YoY to 1 million tonnes in Q2FY27, impacted by below-normal monsoon conditions and supply-side constraints.
- ₹4,750 crore Odisha investment Oct 23
Paradeep Phosphates signed an MoU with the Odisha government to invest ₹4,750 crore in new chemical and fertilizer facilities, boosting industrial capacity and employment.
- Phosphoric acid expansion on track Nov 4
Capacity expansion from 0.5mmtpa to 0.7mmtpa is on track for commissioning in Q1FY28, with further expansion to 1mmtpa targeted by FY29/FY30.
- ₹250 crore aluminium fluoride plant Oct 30
The board approved ₹250 crore investment for a new aluminium fluoride plant, supporting backward integration and diversification.
- Q2FY27 call transcript uploaded Nov 11
Paradeep Phosphates disclosed the transcript of its analyst and investor conference call held on November 3, 2026, per SEBI regulations.
- Independent director tenure ends Nov 3
Satyananda Mishra ceased as Independent Director on November 3, 2026, after completing his second term.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,683 | 2,595 | 2,243 | 2,377 | 4,619 | 4,990 | 4,194 | 4,504 | 6,872 | 5,749 | 4,702 | 6,124 | 7,364 |
| Expenses | 3,427 | 2,313 | 2,095 | 2,231 | 4,112 | 4,551 | 3,811 | 3,923 | 6,216 | 5,276 | 4,260 | 5,404 | 6,951 |
| Operating Profit | 256 | 282 | 148 | 146 | 507 | 438 | 383 | 580 | 657 | 472 | 442 | 720 | 413 |
| OPM % | 7% | 11% | 7% | 6% | 11% | 9% | 9% | 13% | 10% | 8% | 9% | 12% | 6% |
| Other Income | 11 | 9 | 30.03 | 19 | 20 | 42 | 60 | 34 | 42 | 30.98 | 39.84 | 43 | 18 |
| Interest | 96 | 82 | 95 | 91 | 105 | 103 | 119 | 104 | 140 | 127 | 156 | 132 | 158 |
| Depreciation | 51 | 55 | 58 | 61 | 86 | 88 | 86 | 86 | 90 | 102 | 126 | 106 | 109 |
| Exceptional Items | — | — | — | — | — | — | — | — | — | −41.3 | 1.88 | — | — |
| PBT | 120 | 154 | 26 | 13 | 337 | 289 | 238 | 424 | 469 | 233 | 202 | 526 | 164 |
| Tax % | 26% | 29% | 18% | 59% | 24% | 28% | 28% | 25% | 27% | 22% | 23% | 25% | 26% |
| Net Profit | 89 | 109 | 22 | 5 | 255 | 209 | 172 | 317 | 342 | 182 | 156 | 393 | 121 |
| EPS (₹) | 1.10 | 1.34 | 0.26 | 0.07 | 3.13 | 2.57 | 2.11 | 3.88 | 4.19 | 1.75 | 1.50 | 3.78 | 1.17 |
| YoY Sales growth | 29 | −41 | −38 | −22 | 25 | 92 | 87 | 89 | 49 | 15 | 12 | 36 | 7 |
Profit & Loss
₹ Cr| Particulars | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,620 | 3,791 | 4,358 | 4,193 | 5,165 | 7,859 | 13,341 | 11,575 | 16,959 | 21,826 | 23,939 |
| Expenses | 3,241 | 3,367 | 3,906 | 3,726 | 4,616 | 7,175 | 12,525 | 10,903 | 15,384 | 19,618 | 21,890 |
| Operating Profit | 379 | 424 | 452 | 467 | 549 | 684 | 816 | 672 | 1,574 | 2,208 | 2,049 |
| OPM % | 10% | 11% | 10% | 11% | 11% | 9% | 6% | 6% | 9% | 10% | 9% |
| Other Income | 53 | 20 | 29 | 27 | 12 | 27 | 76 | 45 | 124 | 51 | 93 |
| Interest | 242 | 159 | 159 | 192 | 111 | 86 | 291 | 366 | 443 | 528 | 573 |
| Depreciation | 58 | 62 | 70 | 72 | 83 | 90 | 175 | 211 | 344 | 403 | 442 |
| PBT | 131 | 224 | 251 | 230 | 366 | 534 | 426 | 141 | 911 | 1,328 | 1,126 |
| Tax % | 34% | 33% | 37% | 16% | 39% | 26% | 29% | 29% | 27% | 25% | — |
| Net Profit | 87 | 151 | 159 | 193 | 223 | 398 | 304 | 101 | 662 | 996 | 851 |
| EPS (₹) | 1.51 | 2.62 | 2.76 | 3.36 | 3.88 | 6.92 | 3.73 | 1.23 | 8.12 | 9.60 | 8.20 |
| Div. Payout % | 0% | 0% | 36% | 0% | 0% | 0% | 13% | 41% | 12% | 16% | — |
| Sales growth | — | 5 | — | −4 | 23 | 52 | 70 | −13 | 47 | 29 | 16 |
Balance Sheet
₹ Cr| Particulars | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 575 | 575 | 575 | 575 | 575 | 575 | 814 | 815 | 815 | 1,038 | 1,039 |
| Reserves | 670 | 820 | 907 | 1,028 | 1,252 | 1,650 | 2,690 | 2,750 | 5,060 | 5,745 | 6,106 |
| Borrowings | 2,511 | 1,861 | 3,123 | 2,298 | 1,251 | 2,954 | 4,648 | 4,014 | 5,100 | 6,906 | 9,879 |
| Other Liabilities | 828 | 875 | 1,022 | 1,109 | 1,344 | 2,749 | 2,504 | 2,083 | 3,294 | 4,247 | 5,369 |
| Total Liabilities | 4,584 | 4,132 | 5,628 | 5,010 | 4,423 | 7,928 | 10,657 | 9,661 | 14,268 | 17,936 | 22,393 |
| Fixed Assets | 932 | 1,008 | 1,024 | 1,214 | 1,226 | 1,261 | 2,872 | 3,431 | 5,194 | 6,026 | 6,193 |
| CWIP | 243 | 215 | 255 | 149 | 220 | 336 | 697 | 372 | 584 | 424 | 283 |
| Investments | 0 | 0 | 0 | 3 | 125 | 553 | 3 | 3 | 272 | 25 | 212 |
| Other Assets | 3,409 | 2,909 | 4,349 | 3,644 | 2,852 | 5,778 | 7,085 | 5,855 | 8,218 | 11,461 | 15,704 |
| Total Assets | 4,584 | 4,132 | 5,628 | 5,010 | 4,423 | 7,928 | 10,657 | 9,661 | 14,268 | 17,936 | 22,393 |
Cash Flow
₹ Cr| Particulars | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 701 | 804 | −920 | 1,270 | 1,501 | −44 | −2,377 | 1,437 | 1,648 | −1,012 |
| Investing | −132 | 73 | −103 | −143 | −289 | −1,099 | −419 | −367 | −415 | −557 |
| Financing | −589 | −868 | 1,018 | −1,141 | −1,124 | 1,589 | 2,301 | −1,022 | −389 | 998 |
| Net Cash Flow | −20 | 9 | −5 | −15 | 87 | 446 | −495 | 48 | 844 | −571 |
| Free Cash Flow | 535 | 726 | −1,047 | 1,131 | 1,332 | −664 | −2,812 | 1,026 | 1,191 | −1,878 |
| CFO/EBITDA | 193 | 202 | −196 | 278 | 288 | 6 | −274 | 222 | 117 | −33 |
Ratios
| Particulars | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 225 | 184 | 196 | 187 | 82 | 42 | 101 | 86 | 66 | 80 |
| Inventory Days | 106 | 92 | 166 | 134 | 85 | 133 | 77 | 74 | 78 | 105 |
| Days Payable | 77 | 88 | 83 | 100 | 89 | 132 | 66 | 60 | 71 | 70 |
| Cash Conversion Cycle | 253 | 189 | 280 | 221 | 78 | 43 | 112 | 100 | 74 | 115 |
| Working Capital Days | 251 | 188 | 35 | 33 | 25 | −50 | 14 | 13 | −3 | 18 |
| ROCE % | — | 11% | — | 10% | 14% | 15% | 11% | 7% | 15% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Paradeep Phosphates insights
61 extracted metrics across FY19–FY27.
Documents
- Q2 FY27 concall · Nov 2026Transcript PPT Recording
- Q1 FY27 concall · Jul 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT Recording
- Q3 FY26 concall · Feb 2026Transcript PPT
- Q2 FY26 concall · Nov 2025Transcript PPT
- 11 Sep 2026
- 14 Apr 2026
- 27 Jan 2026
- 11 Sep 2025
- 25 Feb 2025
- General announcements 2 Nov 2026
Frequently Asked Questions about Paradeep Phosphates
What does Paradeep Phosphates Ltd do?
Where is Paradeep Phosphates Ltd (PARADEEP) listed?
Which sector does Paradeep Phosphates Ltd belong to?
What is the market capitalisation of Paradeep Phosphates Ltd?
What is the PE ratio of Paradeep Phosphates Ltd?
What is the 52-week high and low of Paradeep Phosphates Ltd?
Does Paradeep Phosphates Ltd pay dividends?
What is the Return on Equity (ROE) of Paradeep Phosphates Ltd?
Company Information
Incorporated in 1981, Paradeep Phosphates Limited is a manufacturer of non-urea fertilizers and India’s second largest private sector phosphatic company. The company is engaged in manufacturing, trading, distribution, and sales of a variety of complex fertilizers such as DAP, three grades of Nitrogen-Phosphorus-Potassium (namely NPK-10, NPK-12, and NP-20), Zypmite, Phospho-gypsum, and Hydroflorosilicic Acid.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PARADEEP.md for Paradeep Phosphates Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.